2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
JACC: Basic to Translational Science
Publisher's siteResearch at a glance
Research activity
My publications
Filter publications
47 publications
2024
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
Journal of the American College of Cardiology
Publisher's site2024
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study
JACC: Cardiovascular Interventions
Publisher's site2024
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Thrombosis and Haemostasis
Publisher's site2023
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot
European Heart Journal
Publisher's site